Listed

Kiora Pharmaceuticals Inc

KPRXNasdaqCIK 1372514HealthcareFiscal year ends Dec 31

Reports and events: 268 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Kiora Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2023-11-0606:05 ET8-K9.01 Financial statements and exhibits0001372514-23-000154
2023-09-2819:06 ET8-K5.07 Shareholder vote results0001372514-23-000132
2023-09-2107:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000129
2023-09-0107:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000125
2023-08-0807:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001372514-23-000118
2023-08-0807:13 ET10-QQuarterly reportPeriod 2023-06-300001372514-23-000117
2023-08-0107:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001372514-23-000112
2023-07-2116:49 ETDEF 14AProxy statementPeriod 2023-08-310001372514-23-000110
2023-07-2017:01 ET8-K3.01 Delisting notice0001372514-23-000107
2023-06-2116:25 ET8-K5.07 Shareholder vote results0001372514-23-000103
2023-06-1516:59 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000101
2023-06-0616:52 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000097
2023-06-0118:01 ETS-1/ARegistration statement, amended0001372514-23-000085
2023-05-1217:03 ETS-1/ARegistration statement, amended0001628280-23-017953
2023-05-0907:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001372514-23-000070
2023-05-0906:59 ET10-QQuarterly reportPeriod 2023-03-310001372514-23-000069
2023-05-0517:01 ETS-1Registration statement0001628280-23-016198
2023-04-2814:16 ETDEF 14AProxy statementPeriod 2023-06-210001372514-23-000059
2023-04-2714:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000057
2023-03-3007:02 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001372514-23-000053
2023-03-2307:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001372514-23-000051
2023-03-2307:01 ET10-KAnnual reportPeriod 2022-12-310001372514-23-000050
2023-02-0707:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000010
2023-02-0317:21 ETS-1Registration statement0001104659-23-010675
2023-02-0307:01 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001372514-23-000008
2023-01-0916:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-002295
2023-01-0316:31 ET8-K8.01 Other events0001104659-23-000363
2022-12-2219:30 ETS-1Registration statement0001104659-22-129237
2022-11-2107:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-120486
2022-11-0906:04 ET10-QQuarterly reportPeriod 2022-09-300001410578-22-003035
2022-10-1306:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-108263
2022-09-2606:45 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-102816
2022-09-2316:30 ET8-K5.07 Shareholder vote results0001104659-22-102697
2022-09-1616:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-100852
2022-08-2516:33 ET8-K3.01 Delisting notice0001104659-22-094445
2022-08-1517:56 ETDEF 14AProxy statementPeriod 2022-09-230001104659-22-091303
2022-08-1206:18 ET10-QQuarterly reportPeriod 2022-06-300001410578-22-002336
2022-08-0816:30 ETDEF 14AProxy statementPeriod 2022-09-150001104659-22-087273
2022-08-0416:36 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-22-086182
2022-07-2616:31 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-082802
2022-07-2119:23 ETS-1/ARegistration statement, amended0001104659-22-081271
2022-07-1917:14 ETS-1/ARegistration statement, amended0001104659-22-080880
2022-07-1317:24 ETS-1/ARegistration statement, amended0001104659-22-079591
2022-07-0817:00 ET10-QQuarterly reportPeriod 2022-03-310001410578-22-001934
2022-07-0717:34 ET10-K/AAnnual report, amendedPeriod 2021-12-310001410578-22-001931
2022-06-2117:19 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-073063
2022-05-3116:30 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-066571
2022-05-2316:30 ET8-K4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits0001104659-22-063871
2022-05-0316:38 ETS-1Registration statement0001104659-22-055297
2022-04-2606:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-049935

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:43 ET. Listed shows no prices and gives no investment advice.